Congress:
ECR25
Poster Number:
C-16872
Type:
Poster: EPOS Radiologist (scientific)
Authorblock:
V. Arpaia, A. E. Antonini, A. Stanzione, R. Liuzzi, F. Rauseo, L. Sommella, A. Brunetti, L. Camera; Napoli/IT
Disclosures:
Valerio Arpaia:
Nothing to disclose
Andrea Ennio Antonini:
Nothing to disclose
Arnaldo Stanzione:
Nothing to disclose
Raffaele Liuzzi:
Nothing to disclose
Francesca Rauseo:
Nothing to disclose
Laura Sommella:
Nothing to disclose
Arturo Brunetti:
Nothing to disclose
Luigi Camera:
Nothing to disclose
Keywords:
Contrast agents, Gastrointestinal tract, Radioprotection / Radiation dose, CT, Contrast agent-intravenous, Dosimetry, Dosimetric comparison
- Population: From March 2023 to December 2024 50 (26M; 24F; aged 61 ± 12.4 yrs) nonconsecutive patients referred to our Institution to undergo a contrast-enhanced MDCT performed with a 128-slice Dual-Energy CT scanner (Somatom Drive, Siemens, Germany) for either a ANTA (n= 20), follow-up examinations (n= 16) or post-operative complications (n=14) were enrolled. Exclusion criteria included the presence of an impaired cardiac (pace-makers holders, EF < 50%) and/or renal function (GFR < 30 ml/min) or the absence of an adequate ante-cubital access vein.
Patients’ weight, height and serum creatinine levels were recorded and Body Mass Indices (BMI, Kg/m2) as well as Glomerular Filtration Rates (GFR, ml/min) based on the CKD-EPI formula (14) were calculated.
Based on BMI, patients were further divided into two groups (A and B) with an arbitrary threshold set at 23.9 Kg/m2 (Table 1).
- CT protocol: All patients underwent a SP protocol performed using a SS (100 kVp) integrated by a delayed phase at 3-5’ performed with a DS at 80 and 140 kVp. Both SS and DS acquisitions were acquired with the following scanning parameters: detector configuration 128 x 0.6 mm; table feed: 123 mm/s; rotation time: 0.5 s; pitchX/D: 0.8/102; reconstruction thickness: 3 mm; reconstruction interval: 1.5 mm.
In all patients the SP protocol was acquired with a FID (50 s) according to the following formula:
50+ 25 – SD
where 25 is the average of the sum of the abdominal aortic (15 s) and hepatic arrival times (35s) (15) and SD is the scan duration.
- Iodinated contrast media: All patients received a non-ionic iodinated contrast media (370 mgI/ml, Bracco Imaging S.p.A., Milan, Italy) with an Iodine load of 0.52 gI/Kg corresponding to 1.4 ml/Kg according to vendor indications (Siemens Healthineers). In all patients, contrast injection was followed by a saline flush administered at the same rate using a dual-head automatic injector (Enpower CTA, Bracco Imaging S.p.A, Milan).
- Dosimetry: In all patients, the radiation dose delivered was reported as both volumetric CT Dose Index (CTDIvol, mGy) and Dose-Length Product (DLP, mGy *cm).
- Image quality analysis: Quantitative analysis was performed on a dedicated workstation (OsiriX Imaging Software) on the coronal reformatted images (Figure 1). Four circular regions of interest (ROIs) ranging between 0.5 and 2 cm2 were placed in the liver parenchyma, in the supra- and infra-renal abdominal aorta, the main portal vein and the psoas muscles (Figure 1a-c). The mean values in Hounsfield Units measured in each ROI were recorded and averaged to obtain the mean (m) for the liver (mL), the abdominal aorta (mAA), the main portal vein (mPV) and the psoas muscle (mM). Values of standard deviation (SD) in each ROI were also recorded and averaged to obtain the mean SD for the liver (SDL), the abdominal aorta (SDAA), the main portal vein (SDPV) and the psoas muscles, this latter taken as the image noise (s). Signal- and contrast-to-noise ratios were the calculated for the liver (SNRL, CNRL), the abdominal aorta (SNRAA,, CNRAA) and the main portal vein (SNRPV, CNRPV) as previously reported (11).
- Statistical analysis: Dosimetric data were compared using a paired Student’s t-test whereas an unpaired t-Test was used for the image quality evaluation between patients of Group A and B, both with a significance level (p) set at < 0.05.